We’re taking aim at chronic disease and we won’t give up until we conquer.

Biospherics, a wholly owned subsidiary of Spherix Incorporated, is a leader in the application of chiral carbohydrate chemistry.  The Company’s lead clinical candidate is D-Tagatose, an FDA-approved, naturally occurring, simple sugar being developed as an oral treatment for glycemic control in patients with Type 2 diabetes as well as other indications.